Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

TRANSITION THERAPEUTICS INC. T.TTH

"Transition Therapeutics Inc is a product-focused biopharmaceutical company. The Company is engaged in developing therapeutics for disease indications with markets. Its technologies are focused on the treatment of Alzheimer's disease and diabetes."


TSX:TTH - Post by User

Post by deninsaskon Dec 20, 2007 2:48pm
236 Views
Post# 14053998

The Elan Benefits START !!! NOW !!!

The Elan Benefits START !!! NOW !!! Interesting to note that Elan has AZD-103 Phasell Recruiting as we speak and their other AD Drug is set to go but not yet recruiting..........However the Phone number for THAT Trial 1-888-818-MEMORY asks the Patient if they are Applying for ORAL OR INFUSION? They will then give you the appropriate Phone Number for either the AZD-103 Phasell Trial (Oral)1-877-687-8839 (same as on Clinicaltrials.gov) or for Elans aab001 Trial. I think its great that Elan is giving the Callers the Opportunity to choose AZD-103 when calling about their Other Trial immunotherapy........simply because it Greatly Increases Exposure for AZD-103!! GREAT NEWS!!! BooooooYaaaaah!!!!
Bullboard Posts